Clinician’s guide for dapagliflozin use in heart failure with reduced ejection fraction
نویسندگان
چکیده
Dapagliflozin belongs to a new class of drugs used for the treatment heart failure — sodium-glucose cotransporter type 2 inhibitors (SGLT2i). Based on DAPA-HF study results, dapagliflozin has become first SGLT2i approved symptomatic chronic with reduced ejection fraction. The present review summarizes most important clinical issues related this drug.
منابع مشابه
Chronic heart failure with reduced ejection fraction.
Heart failure with reduced ejection fraction is a clinical syndrome of dysp nea, exercise intolerance and/or edema resulting from an impairment of ejec tion of blood, usually documented by a left ventricular ejection fraction of 40% or less on echocardiography.1,2 Cor on ary artery disease is a major cause; therefore, stress testing or, in the pres ence of angina, coronary angiography shoul...
متن کاملCosts for heart failure with normal vs reduced ejection fraction.
BACKGROUND Among the elderly population, heart failure (HF) with normal ejection fraction (EF) is more common than classic HF with low EF. However, there are few data regarding the costs of HF with normal EF. In a prospective, population-based cohort of elderly participants, we compared the costs and resource use of patients with HF and normal and reduced EF. METHODS A total of 4549 participa...
متن کاملOral Iron Therapy for Heart Failure With Reduced Ejection Fraction
Impaired exercise capacity is a cardinal manifestation of heart failure (HF) that is closely related to reduced quality of life and poor outcomes. Therapeutic options beyond neurohormonal blockade to improve functional capacity and symptoms in HF are currently limited and must be pursued. Iron deficiency is associated with reduced functional capacity and poorer quality of life in HF. Here, a ra...
متن کاملA Practical Guide for the Treatment of Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF)
This review will outline the management of patients with symptomatic systolic heart failure or heart failure with reduced ejection fraction (HFrEF), i.e., those with structural heart disease and previous or current symptoms. Determination of volume status and appropriate diuretic administration is important in heart failure management. Inhibition of the renin-angiotensin-aldosterone and sympath...
متن کاملNew biomarker in heart failure with reduced ejection fraction.
eart failure is a serious condition because of the structural and/or functional cardiac disorders,1–3 in which not only heart failure with preserved ejection fraction (HFpEF) but also heart failure with reduced ejection fraction (HFrEF) are substantially involved.4,5 Because of the poor prognosis of patients, especially those with HFrEF,6 various therapeutic options have been developed during t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Folia Cardiologica
سال: 2021
ISSN: ['2353-7752', '2353-7760']
DOI: https://doi.org/10.5603/fc.2021.0022